PAZOPANIB ZENTIVA
Film-coated tablet, 200mg
RxActive license
Active substance (INN)
pazopanib
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength200mg
PackagingUkupno 30 film tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerRemedica Ltd., Cyprus
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX03)
Marketing authorization holderZENTIVA PHARMA DOO - DIO STRANOG DRUŠTVA PODGORICA
Authorization dateJanuary 19, 2024
Analogs in Montenegro
16Other medicines with the same active substance
FRONTIENTRx
Film-coated tablet, 400mgFRONTIENTRx
Film-coated tablet, 200mgLIBURADONERx
Film-coated tablet, 200mgLIBURADONERx
Film-coated tablet, 400mgPARIZOLRx
Film-coated tablet, 400mgPARIZOLRx
Film-coated tablet, 200 mgPAZOPANIB HFRx
Film-coated tablet, 200mgPAZOPANIB HFRx
Film-coated tablet, 200mgPAZOPANIB HFRx
Film-coated tablet, 400mgPAZOPANIB SKRx
Film-coated tablet, 400mgPAZOPANIB SKRx
Film-coated tablet, 200mgPAZOPANIB TEVARestricted
Film-coated tablet, 200mgPAZOPANIB TEVARestricted
Film-coated tablet, 400mgPAZOPANIB ZENTIVARx
Film-coated tablet, 400mgVOTRIENTRx
Film-coated tablet, 400mgVOTRIENTRx
Film-coated tablet, 200mgSource: CInMED register